Source disclosure: February 13, 2026
Mental Health Technologies Co., Ltd. [9218.T]
TOKYO, Feb 13 (Reuters) - Mental Health Technologies Co., Ltd. (Tokyo Growth Market: 9218), reported on Monday that its sales surged by 19.0 percent year-over-year in the fiscal year ending December 2025. The company's consolidated revenue reached ¥12 billion, reflecting robust growth across all segments of its business.
The report highlighted significant contributions from both the mental health solutions segment and the medical workforce shift segment. Specifically, the mental health solution business, abbreviated as MHS, saw substantial gains due to increased demand for their cloud-based occupational health services and clinic operation support systems. This segment alone contributed approximately ¥7.5 billion to the total revenue, marking an increase of 20.5 percent compared to the previous fiscal year. Additionally, the medical workforce shift business, known as MWS, which provides staffing services primarily to large acute care hospitals, also showed strong performance, contributing about ¥3.5 billion, up by 16.7 percent year-on-year.
In detail, the key performance indicators (KPIs) for the mental health solutions business were particularly noteworthy. The net revenue retention rate (NRR) stood at 110 percent as of December 2025, indicating high customer satisfaction and loyalty. Furthermore, the monthly recurring revenue (MRR) continued to grow steadily, reaching ¥625 million in the final quarter of the fiscal year, demonstrating consistent subscription-based income. These metrics underscore the effectiveness of the company’s strategies aimed at enhancing customer value through upselling initiatives and platform offerings designed to support enterprise clients with over 1,000 employees and small-to-medium businesses (SMB).
AI-translated content. 🟢 Confidence: High See terms • Original filing